New gene test on the market
The Medical Prognosis Institute in cooporation with Capio Diagnostik and Roche Diagnostics is launching a gene test that is capable of determining the correct doses of critical medicine. This opens the path to personalized medication. The product will be on the market in the beginning of June.


